Lowered costs of genomic sequencing facilitate analyzing large segments of genetic data. Ethical debate has focused on whether and what kind of incidental or secondary findings (SFs) to report, and how to obtain valid informed consent. However, people's support needs after receiving SFs have received less attention. We explored Finnish adults' perspectives on reporting genetic SFs. In this qualitative study which included four focus group discussions (N = 23) we used four vignette letters, each reporting a genetic SF predisposing to a different disease: familial hypercholesterolemia, long QT syndrome, Lynch syndrome, and Li-Fraumeni syndrome. Transcribed focus group discussions were analyzed using inductive thematic analysis. Major themes w...
The clinical application of new genetic technologies will be and already is of great benefit to chil...
Incidental findings, results that exceed the initial indication for a medical test, are of the most ...
Analysis of whole genome sequence data can reveal information of clinical relevance to data subjects...
Lowered costs of genomic sequencing facilitate analyzing large segments of genetic data. Ethical deb...
Lowered costs of genomic sequencing facilitate analyzing large segments of genetic data. Ethical deb...
Genome‐wide sequencing may generate secondary findings (SFs). It is recommended that validated, clin...
Incidental or secondary findings (ISFs) are currently among the most debated topics in the domain of...
Genome-wide sequencing may generate secondary findings (SFs). It is recommended that validated, clin...
Background and research objectives Genetic testing is becoming a standard procedure in clinical care...
With large-scale genome sequencing initiatives underway, vast amounts of genomic data are being gene...
Exome/genome sequencing (ES/GS) is increasingly becoming routine in clinical genetic diagnosis, yet ...
Background: Technological developments and discussions around autonomy and paternalism in clinical p...
With transformative initiatives like the UK’s 100,000 Genomes Project underway, vast amounts of data...
Rapidly declining costs and increasing availability of whole-genome analysis means that clinical gen...
Purpose: As whole-exome and whole-genome sequencing (WES/WGS) move into routine clinical practice, i...
The clinical application of new genetic technologies will be and already is of great benefit to chil...
Incidental findings, results that exceed the initial indication for a medical test, are of the most ...
Analysis of whole genome sequence data can reveal information of clinical relevance to data subjects...
Lowered costs of genomic sequencing facilitate analyzing large segments of genetic data. Ethical deb...
Lowered costs of genomic sequencing facilitate analyzing large segments of genetic data. Ethical deb...
Genome‐wide sequencing may generate secondary findings (SFs). It is recommended that validated, clin...
Incidental or secondary findings (ISFs) are currently among the most debated topics in the domain of...
Genome-wide sequencing may generate secondary findings (SFs). It is recommended that validated, clin...
Background and research objectives Genetic testing is becoming a standard procedure in clinical care...
With large-scale genome sequencing initiatives underway, vast amounts of genomic data are being gene...
Exome/genome sequencing (ES/GS) is increasingly becoming routine in clinical genetic diagnosis, yet ...
Background: Technological developments and discussions around autonomy and paternalism in clinical p...
With transformative initiatives like the UK’s 100,000 Genomes Project underway, vast amounts of data...
Rapidly declining costs and increasing availability of whole-genome analysis means that clinical gen...
Purpose: As whole-exome and whole-genome sequencing (WES/WGS) move into routine clinical practice, i...
The clinical application of new genetic technologies will be and already is of great benefit to chil...
Incidental findings, results that exceed the initial indication for a medical test, are of the most ...
Analysis of whole genome sequence data can reveal information of clinical relevance to data subjects...